Neuralink ha recibido recientemente la autorización de la Administración de Alimentos y Medicamentos de EE.UU. para realizar ensayos clínicos en humanos
Neuralink, the futuristic brain-computer interface company founded by Elon Musk, said it has raised US$205 million in fresh venture backing, by far the biggest haul of any company in its field.
